Inactive Instrument

Highlights Cesca Therapeutics Inc Nasdaq

Equities

US1571311034

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

ThermoGenesis Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
ThermoGenesis Holdings, Inc. to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento	23-10-26	CI
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
ThermoGenesis Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
ThermoGenesis Holdings, Inc. acquired CDMO facility.	23-03-29	CI
ThermoGenesis to Launch California Facility for Early-Stage Life Science, Cell Gene Therapy Companies; Shares Rise	23-03-15	MT
ThermoGenesis Holdings, Inc. Announces Roll Out of Readystart Cgmp Suites for Early-Stage Cell and Gene Therapy Companies	23-03-15	CI
ThermoGenesis Regains Compliance With Nasdaq's Bid Price Rule	23-01-11	MT
Reverse Split: 1 of 45	22-12-21	FA
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
ETF Preview: ETFs, Futures Fall Pre-Bell After International Trade, Inventories Data	22-10-26	MT
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
ThermoGenesis Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-19	CI
Thermogenesis Holdings, Inc. Leases 35,475 SF to Be Built-Out as cGMP Compliant Facility in Sacramento	22-03-28	CI
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-28	CI
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
ThermoGenesis Q3 Loss Narrows as Revenue Climbs	21-11-12	MT
ThermoGenesis : Receives $250,000 Grant to Develop Key Cell Processing Disposable for Quintessence System	21-09-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cesca Therapeutics Inc Nasdaq

Equities

US1571311034

Highlights

Filters